Sort   by:  
 Page size 
UnknownGM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents.
Not available
S-EPMC11039472 | biostudies-literature
UnknownCardiovascular status after Kawasaki disease in the UK.
Not available
S-EPMC4621377 | biostudies-literature
UnknownPast, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Not available
S-EPMC5685546 | biostudies-literature
Unknown<i>LRRK2</i>-associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization.
Not available
S-EPMC11925012 | biostudies-literature
UnknownNeuronal α-Synuclein Disease Stage Progression over 5 Years.
Not available
S-EPMC12273616 | biostudies-literature
UnknownGenomewide association study for onset age in Parkinson disease.
Not available
S-EPMC2758866 | biostudies-literature
UnknownGenomewide association study for susceptibility genes contributing to familial Parkinson disease.
Not available
S-EPMC2627511 | biostudies-literature
UnknownUnderrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.
Not available
S-EPMC10360137 | biostudies-literature
UnknownNeuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
Not available
S-EPMC11567150 | biostudies-literature
UnknownTMEM175, SCARB2 and CTSB associations with Parkinson's disease risk across populations.
Not available
S-EPMC12678402 | biostudies-literature
Sort   by:  
 Page size